US Broker Ratings

Gilead Sciences (GILD) Stock Analysis: A Healthcare Giant with a Robust 5% Potential Upside

Gilead Sciences, Inc. (NASDAQ: GILD) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry. Headquartered in Foster City, California, Gilead..

Insulet Corporation (PODD) Stock Analysis: Exploring a Promising 43.71% Upside in the Medical Devices Sector

Insulet Corporation (PODD), a prominent player in the healthcare sector, specifically within the medical devices industry, is drawing significant interest from investors due to its innovative..

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 62.87% Upside Potential in Health Information Services

Doximity, Inc. (NYSE: DOCS) stands as a prominent name in the healthcare sector, particularly within the health information services industry. Known for its digital platform tailored..

Globus Medical, Inc. (GMED) Stock Analysis: A Healthcare Innovator with 14.75% Upside Potential

Globus Medical, Inc. (NYSE: GMED), a leader in the healthcare sector, is attracting investor attention with its robust growth potential and innovative solutions for musculoskeletal disorders...

Vertex Pharmaceuticals (VRTX) Stock Analysis: Poised for Growth with a 7.27% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a powerhouse in the biotechnology sector, continues to make waves with its innovative approach to addressing severe diseases. With a market..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 22% Potential Upside

In the competitive landscape of healthcare, Universal Health Services, Inc. (NYSE: UHS) stands out as a formidable player with a promising outlook for investors. Headquartered in..

Insmed Incorporated (INSM): Investor Outlook Reveals a Promising 42% Upside

Insmed Incorporated (NASDAQ: INSM), a biotechnology firm headquartered in Bridgewater, New Jersey, is making waves in the healthcare sector with a notable potential upside of 42.32%...

DexCom, Inc. (DXCM) Stock Analysis: 16.91% Potential Upside Amid Robust Growth Metrics

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector’s medical devices industry, has been revolutionizing diabetes management through its cutting-edge continuous glucose monitoring (CGM) systems...

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: An 84.90% Revenue Surge and 37.27% Upside Potential

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a pioneering entity in RNA interference therapeutics, has been generating buzz in the biotechnology sector with its impressive revenue growth and..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 34.15% Upside Potential in the Healthcare Sector

Agilent Technologies, Inc. (NYSE: A) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A 12.36% Upside Beckons in Healthcare Innovation

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a stalwart in the healthcare sector, has long stood at the forefront of the drug manufacturing industry, particularly specializing in..

Hologic, Inc. (HOLX) Stock Analysis: Navigating Growth in the Medical Instruments Sector

Hologic, Inc. (NASDAQ: HOLX) stands at the forefront of the healthcare sector, specializing in medical instruments and supplies with a primary focus on women’s health. With..

AptarGroup, Inc. (ATR) Stock Analysis: An Investor’s Guide to a 12% Potential Upside

AptarGroup, Inc. (NYSE: ATR), a leading player in the medical instruments and supplies industry, presents a compelling investment opportunity with a potential upside of 12.33%, as..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating Its 2.09% Dividend Yield Amid Market Dynamics

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, stands as a stalwart among drug manufacturers in the United States. With a staggering market..

BioMarin Pharmaceutical (BMRN) Stock Analysis: Exploring a 42.84% Potential Upside Amidst Robust Growth

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is making waves in the biotechnology sector, attracting the attention of individual investors with its promising outlook and notable growth metrics...

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Potential 27.89% Upside Amid Robust Growth and Strategic Positioning

As investors navigate the complex landscape of the healthcare sector, Thermo Fisher Scientific Inc (NYSE: TMO) stands out as a formidable player within the diagnostics and..

United Therapeutics (UTHR): Investor Outlook with a 13% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR) remains a compelling focus for investors in the healthcare sector, particularly those interested in the specialty and generic drug manufacturing industry...

Tenet Healthcare Corporation (THC) Stock Analysis: A Strong Buy with 7.36% Potential Upside

Tenet Healthcare Corporation (NYSE: THC) stands as a prominent player in the U.S. healthcare sector, showcasing impressive growth and robust market positioning. With a market capitalization..

Stryker Corporation (SYK) Stock Analysis: A Healthcare Giant with Promising Upside Potential

Stryker Corporation (NYSE: SYK), a heavyweight in the healthcare sector, is widely recognized for its innovative contributions to medical devices. With a robust market capitalization of..

West Pharmaceutical Services (WST) Stock Analysis: Unveiling a Promising 25% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST) offers a compelling opportunity for investors looking to capitalize on the robust growth and innovation in the healthcare sector. Specializing..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds